Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 2 Breast Neoplasms 2 Acquired Immunodeficiency Syndrome 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Sexually Transmitted Diseases 1 Lung Neoplasms 1 High-grade Anal Intraepithelial Neoplasia 1 HIV Infections 1 Condylomata Acuminata 1 Benign Ovarian Tumor 1 Anus Neoplasms 1

Interventions

Colposcopy 13 Imiquimod 12 Conization 11 Papillomavirus Vaccines 8 Cryotherapy 6 Vaccines 5 Papanicolaou Test 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Acetic Acid 4 Watchful Waiting 3 Vaginal Smears 3 Surveys and Questionnaires 3 Biopsy 3 human papillomavirus vaccine, L1 type 16, 18 2 Spectrometry, Fluorescence 2 Proflavine 2 Mass Screening 2 Immunohistochemistry 2 Human Papillomavirus DNA Tests 2 High-Throughput Screening Assays 2 Flow Cytometry 2 Curcumin 2 Blood Specimen Collection 2 pembrolizumab 1 nimotuzumab 1 lime 1 human papillomavirus vaccine, TA 1 hecolin 1 efineptakin alfa 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uterine Cervical Dysplasia × Electrocoagulation × Clear all

NCT02956239 2024-07-08

DELTA

International Agency for Research on Cancer

Phase NA Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡